Clinical Research & Trials

Clinical Research focuses on the operational conduct, monitoring and scientific direction of clinical trials for investigational and marketed medicines — coordinating sites, verifying source data, ensuring GCP/regulatory compliance, and at senior levels designing protocols and directing full clinical development programs. Distinct from sibling focuses in Data Management (database build/cleaning), Biostatistics (statistical analysis) and Regulatory Affairs (submission ownership), this focus owns subject-facing trial execution and the clinical strategy behind it.

25 leveled profiles. Pick a level to see the full profile.

Individual contributor

P1Clinical Research — P1

Clinical Research focuses on the operational conduct, monitoring and scientific direction of clinical trials for investigational and marketed medicines — coordinating sites, verifying source data, ensuring GCP/regulatory compliance, and at senior levels designing protocols and directing full clinical development programs. Distinct from sibling focuses in Data Management (database build/cleaning), Biostatistics (statistical analysis) and Regulatory Affairs (submission ownership), this focus owns subject-facing trial execution and the clinical strategy behind it.

P1Clinical Trials Administration — P1

Focuses on the operational administration and coordination of clinical trials at the study and site level — participant enrollment and informed consent, study record and regulatory documentation maintenance, site monitoring oversight, vendor and budget coordination, and end-to-end trial delivery from start-up through close-out. Distinct from sibling focuses in Data Management (EDC design and data validation), Biostatistics (statistical analysis), and Pharmacovigilance (drug safety surveillance) — this focus owns the operational orchestration and GCP-compliant conduct of the trial itself rather than the analytic or safety-specific deliverables.

P2Clinical Trials Administration — P2

Focuses on the operational administration and coordination of clinical trials at the study and site level — participant enrollment and informed consent, study record and regulatory documentation maintenance, site monitoring oversight, vendor and budget coordination, and end-to-end trial delivery from start-up through close-out. Distinct from sibling focuses in Data Management (EDC design and data validation), Biostatistics (statistical analysis), and Pharmacovigilance (drug safety surveillance) — this focus owns the operational orchestration and GCP-compliant conduct of the trial itself rather than the analytic or safety-specific deliverables.

P2Clinical Research — P2

Clinical Research focuses on the operational conduct, monitoring and scientific direction of clinical trials for investigational and marketed medicines — coordinating sites, verifying source data, ensuring GCP/regulatory compliance, and at senior levels designing protocols and directing full clinical development programs. Distinct from sibling focuses in Data Management (database build/cleaning), Biostatistics (statistical analysis) and Regulatory Affairs (submission ownership), this focus owns subject-facing trial execution and the clinical strategy behind it.

P2Clinical Operations — P2

Clinical Operations focuses on the hands-on execution and oversight of clinical trials — from coordinator-level subject visits, scheduling, and protocol procedures, through site monitoring, study document and CTMS/EDC management, adverse event handling, vendor/CRO oversight, recruitment tracking, and protocol compliance, up to portfolio strategy and global trial operations ownership. Distinct from Clinical Data Management (data cleaning/database lock), Biostatistics (statistical design/analysis), Regulatory Affairs (submissions/agency interaction), and Medical/Safety (medical monitoring/pharmacovigilance) — Clinical Operations owns the operational running of trials end-to-end.

P3Clinical Operations — P3

Clinical Operations focuses on the hands-on execution and oversight of clinical trials — from coordinator-level subject visits, scheduling, and protocol procedures, through site monitoring, study document and CTMS/EDC management, adverse event handling, vendor/CRO oversight, recruitment tracking, and protocol compliance, up to portfolio strategy and global trial operations ownership. Distinct from Clinical Data Management (data cleaning/database lock), Biostatistics (statistical design/analysis), Regulatory Affairs (submissions/agency interaction), and Medical/Safety (medical monitoring/pharmacovigilance) — Clinical Operations owns the operational running of trials end-to-end.

P3Clinical Trials Administration — P3

Focuses on the operational administration and coordination of clinical trials at the study and site level — participant enrollment and informed consent, study record and regulatory documentation maintenance, site monitoring oversight, vendor and budget coordination, and end-to-end trial delivery from start-up through close-out. Distinct from sibling focuses in Data Management (EDC design and data validation), Biostatistics (statistical analysis), and Pharmacovigilance (drug safety surveillance) — this focus owns the operational orchestration and GCP-compliant conduct of the trial itself rather than the analytic or safety-specific deliverables.

P3Clinical Research — P3

Clinical Research focuses on the operational conduct, monitoring and scientific direction of clinical trials for investigational and marketed medicines — coordinating sites, verifying source data, ensuring GCP/regulatory compliance, and at senior levels designing protocols and directing full clinical development programs. Distinct from sibling focuses in Data Management (database build/cleaning), Biostatistics (statistical analysis) and Regulatory Affairs (submission ownership), this focus owns subject-facing trial execution and the clinical strategy behind it.

P4Clinical Trials Administration — P4

Focuses on the operational administration and coordination of clinical trials at the study and site level — participant enrollment and informed consent, study record and regulatory documentation maintenance, site monitoring oversight, vendor and budget coordination, and end-to-end trial delivery from start-up through close-out. Distinct from sibling focuses in Data Management (EDC design and data validation), Biostatistics (statistical analysis), and Pharmacovigilance (drug safety surveillance) — this focus owns the operational orchestration and GCP-compliant conduct of the trial itself rather than the analytic or safety-specific deliverables.

P4Clinical Research — P4

Clinical Research focuses on the operational conduct, monitoring and scientific direction of clinical trials for investigational and marketed medicines — coordinating sites, verifying source data, ensuring GCP/regulatory compliance, and at senior levels designing protocols and directing full clinical development programs. Distinct from sibling focuses in Data Management (database build/cleaning), Biostatistics (statistical analysis) and Regulatory Affairs (submission ownership), this focus owns subject-facing trial execution and the clinical strategy behind it.

P4Clinical Operations — P4

Clinical Operations focuses on the hands-on execution and oversight of clinical trials — from coordinator-level subject visits, scheduling, and protocol procedures, through site monitoring, study document and CTMS/EDC management, adverse event handling, vendor/CRO oversight, recruitment tracking, and protocol compliance, up to portfolio strategy and global trial operations ownership. Distinct from Clinical Data Management (data cleaning/database lock), Biostatistics (statistical design/analysis), Regulatory Affairs (submissions/agency interaction), and Medical/Safety (medical monitoring/pharmacovigilance) — Clinical Operations owns the operational running of trials end-to-end.

P5Clinical Research — P5

Clinical Research focuses on the operational conduct, monitoring and scientific direction of clinical trials for investigational and marketed medicines — coordinating sites, verifying source data, ensuring GCP/regulatory compliance, and at senior levels designing protocols and directing full clinical development programs. Distinct from sibling focuses in Data Management (database build/cleaning), Biostatistics (statistical analysis) and Regulatory Affairs (submission ownership), this focus owns subject-facing trial execution and the clinical strategy behind it.

P5Clinical Operations — P5

Clinical Operations focuses on the hands-on execution and oversight of clinical trials — from coordinator-level subject visits, scheduling, and protocol procedures, through site monitoring, study document and CTMS/EDC management, adverse event handling, vendor/CRO oversight, recruitment tracking, and protocol compliance, up to portfolio strategy and global trial operations ownership. Distinct from Clinical Data Management (data cleaning/database lock), Biostatistics (statistical design/analysis), Regulatory Affairs (submissions/agency interaction), and Medical/Safety (medical monitoring/pharmacovigilance) — Clinical Operations owns the operational running of trials end-to-end.

P5Clinical Trials Administration — P5

Focuses on the operational administration and coordination of clinical trials at the study and site level — participant enrollment and informed consent, study record and regulatory documentation maintenance, site monitoring oversight, vendor and budget coordination, and end-to-end trial delivery from start-up through close-out. Distinct from sibling focuses in Data Management (EDC design and data validation), Biostatistics (statistical analysis), and Pharmacovigilance (drug safety surveillance) — this focus owns the operational orchestration and GCP-compliant conduct of the trial itself rather than the analytic or safety-specific deliverables.

P6Clinical Operations — P6

Clinical Operations focuses on the hands-on execution and oversight of clinical trials — from coordinator-level subject visits, scheduling, and protocol procedures, through site monitoring, study document and CTMS/EDC management, adverse event handling, vendor/CRO oversight, recruitment tracking, and protocol compliance, up to portfolio strategy and global trial operations ownership. Distinct from Clinical Data Management (data cleaning/database lock), Biostatistics (statistical design/analysis), Regulatory Affairs (submissions/agency interaction), and Medical/Safety (medical monitoring/pharmacovigilance) — Clinical Operations owns the operational running of trials end-to-end.

P6Clinical Research — P6

Clinical Research focuses on the operational conduct, monitoring and scientific direction of clinical trials for investigational and marketed medicines — coordinating sites, verifying source data, ensuring GCP/regulatory compliance, and at senior levels designing protocols and directing full clinical development programs. Distinct from sibling focuses in Data Management (database build/cleaning), Biostatistics (statistical analysis) and Regulatory Affairs (submission ownership), this focus owns subject-facing trial execution and the clinical strategy behind it.

Management

M1Clinical Project Management — M1

Manages the people, budgets, timelines, and cross-functional delivery of clinical trials and trial portfolios — distinct from Clinical Operations/Monitoring (site-facing CRA execution), Data Management (EDC build/data cleaning), and Regulatory Affairs (submission ownership). This focus owns project/program planning, sponsor relationships, resource allocation, vendor management (IWRS/ePRO/lab/recruitment), and the line-management of Clinical Project Managers across the trial lifecycle from initiation through close-out.

M1Clinical Trials Administration – Management — M1

Management track for clinical trial operations leaders who plan, staff, and deliver clinical studies. Unlike Clinical Monitoring (CRA site-facing data verification) or Data Management (EDC/database) focuses, this focus owns the operational management of study delivery — coordinating timelines, vendors/CROs, budgets, and CTA/CRA teams to ensure GCP-compliant execution across start-up, conduct, and close-out.

M2Clinical Trials Administration – Management — M2

Management track for clinical trial operations leaders who plan, staff, and deliver clinical studies. Unlike Clinical Monitoring (CRA site-facing data verification) or Data Management (EDC/database) focuses, this focus owns the operational management of study delivery — coordinating timelines, vendors/CROs, budgets, and CTA/CRA teams to ensure GCP-compliant execution across start-up, conduct, and close-out.

M2Clinical Project Management — M2

Manages the people, budgets, timelines, and cross-functional delivery of clinical trials and trial portfolios — distinct from Clinical Operations/Monitoring (site-facing CRA execution), Data Management (EDC build/data cleaning), and Regulatory Affairs (submission ownership). This focus owns project/program planning, sponsor relationships, resource allocation, vendor management (IWRS/ePRO/lab/recruitment), and the line-management of Clinical Project Managers across the trial lifecycle from initiation through close-out.

M3Clinical Project Management — M3

Manages the people, budgets, timelines, and cross-functional delivery of clinical trials and trial portfolios — distinct from Clinical Operations/Monitoring (site-facing CRA execution), Data Management (EDC build/data cleaning), and Regulatory Affairs (submission ownership). This focus owns project/program planning, sponsor relationships, resource allocation, vendor management (IWRS/ePRO/lab/recruitment), and the line-management of Clinical Project Managers across the trial lifecycle from initiation through close-out.

M3Clinical Trials Administration – Management — M3

Management track for clinical trial operations leaders who plan, staff, and deliver clinical studies. Unlike Clinical Monitoring (CRA site-facing data verification) or Data Management (EDC/database) focuses, this focus owns the operational management of study delivery — coordinating timelines, vendors/CROs, budgets, and CTA/CRA teams to ensure GCP-compliant execution across start-up, conduct, and close-out.

M4Clinical Trials Administration – Management — M4

Management track for clinical trial operations leaders who plan, staff, and deliver clinical studies. Unlike Clinical Monitoring (CRA site-facing data verification) or Data Management (EDC/database) focuses, this focus owns the operational management of study delivery — coordinating timelines, vendors/CROs, budgets, and CTA/CRA teams to ensure GCP-compliant execution across start-up, conduct, and close-out.

M4Clinical Project Management — M4

Manages the people, budgets, timelines, and cross-functional delivery of clinical trials and trial portfolios — distinct from Clinical Operations/Monitoring (site-facing CRA execution), Data Management (EDC build/data cleaning), and Regulatory Affairs (submission ownership). This focus owns project/program planning, sponsor relationships, resource allocation, vendor management (IWRS/ePRO/lab/recruitment), and the line-management of Clinical Project Managers across the trial lifecycle from initiation through close-out.

M5Clinical Project Management — M5

Manages the people, budgets, timelines, and cross-functional delivery of clinical trials and trial portfolios — distinct from Clinical Operations/Monitoring (site-facing CRA execution), Data Management (EDC build/data cleaning), and Regulatory Affairs (submission ownership). This focus owns project/program planning, sponsor relationships, resource allocation, vendor management (IWRS/ePRO/lab/recruitment), and the line-management of Clinical Project Managers across the trial lifecycle from initiation through close-out.